Chinese Medicine and Supportive Cancer Care: A Model for an Evidence-Based, Integrative Approach

Stephen M Sagar; Raimond Wong Department of Medicine, McMaster University, and Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada

 

Evidence-Based Integ Med 1(1):11-25, 2004. © 2004 Open Mind Journals, Ltd.
Please note an early print version of Evidence-Based Integrative Medicine appeared in 2003.

 

Abstract and Introduction

Abstract

Traditional Chinese medicine (TCM) may be integrated with conventional Western medicine to enhance the care of patients with cancer. Recent evidence confirms a scientific basis for the use of acupuncture, herbs, diet and energy therapies. We suggest a holistic care plan based on the concepts of biological response modification, enhancement of psychoimmunological function, better symptom control and improvement of psychospiritual wellbeing. There is enough preliminary evidence to encourage good quality clinical trials to evaluate the efficacy of integrating TCM into Western cancer care.

Introduction

Recent evidence suggests that many traditional Chinese medical therapies can be effective for the supportive care of cancer patients. This is a review of the published literature (indexed in MEDLINE®) and our own practical experience. It is not intended to be a systematic review, but does provide various levels of evidence that support further research into a developing model of integrative care. Most published studies are at evidence level III; in other words, trials without randomisation, single-group pre-post cohort, time series or matched case-controlled studies. Level I and II evidence from well designed, randomised, controlled trials of appropriate size is emphasised in the text of this review. Because of the paucity of quality data from level I and II evidence, meta-analysis of the data is currently not possible. Well designed, randomised, controlled trials are encouraged in view of the promising initial observations.

Traditional Chinese medicine (TCM) may be practised alongside conventional Western medicine to enhance patient care. The philosophy of TCM proposes novel hypotheses that will support the development of a science-based holistic medicine.

 

 

 

Cancer as a Systemic Disease

In Western medicine, cancer is conventionally viewed from the somatic point of view as a clone of cells that has outgrown its environmental constraints and control mechanisms. These cells are abnormal and are considered to be foreign to the body. The main philosophy of cancer treatment is direct annihilation of the cancer cells using aggressive and destructive therapies. The importance of the body-mind communication network in conventional cancer treatment is being emphasised through the innovative models and clinical practices developed by Carl Simonton, Jeanne Achterberg, David Spiegel, Alistair Cunningham and others. In particular, the science of psychoneuroimmunology has demonstrated a physiological basis for cancer cell transformation through the effects of emotions on cellular immunity and other mechanisms.

In TCM, the development of cancer is viewed as a part of the presenting features of a syndrome representing an imbalance of the whole body-mind network (Macek 1984). In other words, cancer is a systemic disease from the start, and the terrain is considered to be as important as the tumour itself (Schipper et al 1995). It is believed that if one can strengthen and rebalance the body-mind network, the normal pattern will be restored, and this will help to resolve the cancer.

 

Chinese Medicine and Supportive Cancer Care

 The Body-Mind Network

TCM recognises that the human being functions as a body-mind network (Ikemi and Ikemi 1986). The philosophy of TCM analyses the process of body-mind communication, rather than a 'snap shot' of structural, material entities such as molecules. If Western medicine is viewed as the hardware of a computer, TCM could represent the software. It recognises a correspondence between patterns of information that are independent of the carrier of the information. For example, the pattern of information may be similar regardless of whether it is mediated by pulses of hormones and neuropeptides, or the electrophysiological frequency pattern of the heart (Watkins 1995; Dardik 1996; Pennisi 1997; Pert et al 1998; Song et al 1998). Acupuncture stimulation of specific points on the body releases neuropeptides (such as somatostatin and vasoactive intestinal peptide) within the central nervous system (Zhang et al 1997; Zhang et al 1999). The body-mind information system may be partly regulated by the relative contributions of the sympathetic and parasympathetic components of the autonomic nervous system. This corresponds to the traditional Chinese concept of a balance between yin and yang, which represents a pattern of information, rather than concrete material entities. Analysis of the pulse, using the classical Chinese technique, may indicate the relative imbalance. This has been demonstrated indirectly by spectral analysis of the electrocardiogram, using appropriate computer software. Acupuncture has been shown to rebalance the relative contributions of the sympathetic and parasympathetic nervous systems (Haker et al 2000). The patterns of information transfer may interact to entrain and reinforce information flow in a complex dynamic system (Lee and Wei 1983; McCraty et al 1995; Rubik 1995). The system is an autopoietic process. In other words, it can recreate itself and evolve through learning, so that the body can adapt to changing circumstances.

When the person is healthy, communication between systems flows freely through a complex, non-linear heterarchical and hierarchical process of information transfer, via physiological interactions. Metaphorically, mind-body communication is represented by an informatics system of energy-in-motion, in other words, 'e-motion'. Cancer may be associated with a disturbance in information flow, manifest by an over-plastic system that loses process structure and becomes irreversibly chaotic (Coffey 1998; Cuzick et al 1998). Experiments in rats show that chronic restraint stress promotes lymphocyte apoptosis through modulating CD95 gene expression via a pathway that involves opioid receptors (Yin et al 2000). In other words, stress can influence both the function and structure of the nervous system that, in turn, may modulate lymphocyte gene expression, thereby influencing immunity and resistance to cancer (Yin et al 2000). Intervention with a technique such as acupuncture may restore the imbalance in information flow, for example through the autonomic nervous system by balancing the sympathetic and parasympathetic components (Thomas et al 1992; Chao et al 1999). The same model may help us understand how the compassionate intentionality of a healer can restore health through entrainment and normalisation of the imbalanced system (Watkins 1996). To understand these processes, we need to consider systems outside our current reductionist pharmacological model. These may include electromagnetic and non-local effects between molecules and the analysis of information flow between cells by novel mechanisms such as quantum mechanics (Jovanovic-Ignjatic and Rakovic 1999). To understand the concurrent, synergistic contributions of multiple systems, it is necessary to develop computerised algorithmic modelling, such as power spectral analysis (Haker et al 2000), neural networks (Riess and Abbas 2000) and fuzzy logic (Kosko and Isaka 1993).

The beauty of this body-mind network model is that it can combine constitutional personality factors (such as emotions and feelings) with bodily symptoms into a single diagnostic and treatment paradigm. This is represented in TCM terms by patterns of disharmonies in the main organ systems, as well as abnormalities of qi (energy flow), essence (energy reserves), blood, heat and moisture. It is interesting that there is correspondence with the TCM model of cancer predisposition being associated with rising qi (sheng qi) or liver fire (representing anger), and the scientific evidence that repressed anger both suppresses the immune system and may increase the risk of breast cancer in the so-called type C personality (Amkraut and Solomon 1972; Temoshok 1985; Temoshok and Dreher 1992).

In TCM, herbs are used in combinations that enhance their benefits while reducing their side effects (Rosenberg 1997). In effect, multiple low-dose pharmacological agents are being administered synergistically. Western medicine usually focuses on maximally tolerated doses of single agents. Although chemotherapy drugs are usually combined, the reason is to minimise drug resistance, and the consequence can be to further increase drug toxicity. According to TCM practitioners, combinations of herbs can reduce the side effects of anticancer drugs, but further research is indicated to determine their pharmacokinetic interactions with drugs and any potential adverse effects.

Most evidence suggests that acupuncture modulates neurotransmitters, cytokines and neuropeptides through electrophysiological changes in the nervous system (Bucinskaite et al 1996; Dawidson et al 1997). Interaction with the brain stem, hypothalamus, limbic system and autonomic nervous system occurs through either stimulating or suppressing the activity of afferent peripheral nerves (Kerr et al 1978; Kumar et al 1994; Alavi et al 1997; Cho et al 1998; Wu et al 1999; Zonenshayn et al 2000). Acupuncture may also modify the somatic electromagnetic field (Jessel-Kenyon et al 1992). It is a technique that allows us to modulate communication within the body-mind network through concurrent changes in multiple signalling pathways.

 

The roles of TCM in cancer supportive care are illustrated in Figure 1. The goals of cancer treatment should be to increase patients' survival, when possible, and to improve their quality of life. TCM is able to support patients being treated with conventional Western medicine (surgery, radi biological response modification

potentiation of psychospiritual wellbeing.otherapy and chemotherapy) through four major approaches:

  1. biological response modification
  2. increase in psychoneuroimmunological function
  3. improvement of symptom control
  4. potentiation of psychospiritual wellbeing.

Biological Response Modification

Adjunctive Cancer Treatment 

Modification of Tumour Physiology

There is increasing evidence that suggests TCM can favorably modify the tumor response to conventional Western cancer treatment. There is a correspondence between the TCM theory of cancer and recent medical research findings.

TCM herbs have been extensively investigated in the laboratory and are known to have multiple pharmacological effects (Wang et al 1992; Tode et al 1993; Lao et al 1994; Boik 1996; Boik 1997; Kang et al 2000). It is often important to specify the botanical parts from which the herbal agent is prepared, since the active pharmacological agents depend on their source. Radix (Rx) denotes the root, cortex (Cx) denotes the bark or rind and rhizome (Rh) denotes the rhizome. Rx ginseng has antitumour activity, inhibits platelet aggregation and inhibits chemotherapy-induced immunosuppression. Glycyrrhizic acid has antitumour activity, is anti-inflammatory through increasing serum cortisol and also increases natural killer (NK) cell activity against cancer cells. Rx astragali membranaceus is a powerful stimulator of the immune system, has antitumour activity and inhibits platelet aggregation. Rx angelicae sinensis stimulates the immune system, has antitumour activity, inhibits platelet aggregation and inhibits vascular permeability. Rh atractylodis macrocephala has antitumour activity and is an antithrombotic and fibrinolytic agent. Ginkgo biloba has multiple effects including inhibition of platelet activation factor, stimulation of the immune system, fibrinolysis and antithrombosis, scavenging of free radicals and dilation of blood vessels to increase perfusion.

These herbs contain a variety of chemicals that may act synergistically to inhibit tumour cell division, increase tumour cell death (apoptosis), increase the proportion of immune cells within the tumour and increase blood flow through the tumour. This is associated with a change in the balance of cytokines (communicating peptides released by the immune cells) that may improve the therapeutic gain. This means that they reduce the proliferation of tumour cells and increase tumour cell death, while minimising many side effects for normal tissues. Examples of studies that illustrate these principles are discussed.

In TCM, the malignant tumour is viewed as being associated with stagnation of qi (energy) and blood. Qi may be viewed as a model for intra- and inter-cellular information and potential energy transfer. This would correlate with the known abnormalities of signal transduction, cell contact and electrophysiology of cancer cells (Coffey 1998; Cuzick et al 1998; Kang et al 2000). It has been shown that there is increased fluid content and a stagnant blood supply in malignant tumours (Baxter and Jain 1989; Boucher and Jain 1992; Sagar et al 1993; Milosevic et al 1998). The microcirculation within a tumour is very abnormal, and there are regions within the tumour where the blood flow is sluggish. In TCM, stagnation of blood is classically associated with tumours. The impaired blood circulation leads to areas of poor oxygenation in the tumour. Cancer cells that survive in a low oxygen tension environment are also found to be more resistant to radiotherapy and some types of chemotherapy (Brizel et al 1997; Fyles et al 1998).

In TCM, destagnation or detoxification herbs are used to move the blood and qi within the malignant tumour. Interestingly, the use of anticoagulants, such as heparin and coumadin (warfarin), as an adjunctive treatment to chemotherapy has been shown to prevent the development of blood-borne metastases in animal laboratory studies and to improve the survival of cancer patients in clinical studies (Lebeau et al 1994; Hejna et al 1999).

The possible usefulness of destagnation herbs was demonstrated in a randomised, controlled clinical trial evaluating the combined modality treatment of Chinese herbal destagnation formula and radiotherapy in patients with nasopharyngeal carcinoma (Xu et al 1989). In this trial, 90 patients received combined herbal and radiation treatment compared with 98 patients who were randomised to receive radiation treatment alone. The ingredients of the herbal formula included Rx astragali membranaceus, Rx paeoniae rubrae, Rx ligustici Chuan xiong, Rx angelicae sinensis, Semen persicae, Flos carthami tinctorii, Rx et Caulis jixueteng, Rx puerariae, Pericarpium citri reticulatae and Rx codonopsitis pilosulae. The combined treatment group showed a statistically significant increase in local tumour control and overall 5-year survival as compared with the group treated with radiation alone (p < 0.05). The rate of local recurrence in the intervention group was halved from 29% in those receiving radiation alone to 14% in the group receiving destagnation herbs as well. The 5-year disease-free survival was increased from 37% in the control group to 53% in the group receiving destagnation herbs. It is postulated that this herbal destagnation formula may have improved tumour microcirculation and increased tumour blood flow, leading to an improvement in the oxygen tension inside the tumour. The oxygen tension increases the radiosensitivity of the tumour. In other words, the destagnation formula has acted as a radiation sensitiser.

In animal experiments, Ginkgo biloba has also been shown to increase perfusion and radiosensitivity (Kleijnen and Knipschild 1992; Sung et al 1996). Chinese herbs, such as Salvia miltiorrhiza, which inhibit tumour oedema caused by free radicals, may also increase tumour perfusion, oxygenation and response to radiotherapy (Sagar et al 1995; Peigen et al 1996). Other herbs may directly sensitise neoplastic cells to radiotherapy (Huali et al 1994). More clinical trials need to be done to further evaluate this promising role of herbs, and tumour blood flow needs to be monitored using non-invasive techniques such as functional magnetic resonance imaging and positron emission tomography (Sagar et al 1993).

Acupuncture. The interaction of acupuncture with appropriate acupoints modulates blood flow (Thomas et al 1992; Zhou et al 1995; Stener-Victorin et al 1996; Chao et al 1999). This may be through a local effect via release of cytokines, or through neurological reflexes that adjust the balance between the sympathetic and parasympathetic nervous systems. Its effect on tumour physiology and response to therapy remains to be investigated. However, we do know that electric pulses to the tumour can increase the response to chemotherapy. A phase II study of electro-chemotherapy using cisplatin in patients with skin nodules from malignant melanoma demonstrated a significantly increased control rate compared with cisplatin alone (Sersa et al 2000). However, the effect of acupuncture may be more diverse through the promotion of local cytokines at physiological levels.

Enhancement of Immunity

Herbs. Another strategy that TCM uses in cancer therapy is to strengthen the whole body-mind system by enhancing and harmonising the energy balance between all the organs. This may be viewed as correcting an imbalance in the body-mind communication network and is reflected by an enhancement in immunity. This is called Fu Zheng treatment and is mediated by the specific group of TCM herbs called Fu Zheng herbs (Ning et al 1988; Ling et al 1989; Chen 1990; Yu et al 1990; Hou et al 1991; Rao et al 1991; Li 1992; Yu et al 1993; Cao et al 1994; Cheng 1994; Horie et al 1994; Lin et al 1995). There is some limited evidence that improvement of the immunological function of cancer patients is associated with an improvement in their survival. In China, Fu Zheng herbs have been reported to increase survival when combined with radiotherapy for patients with nasopharyngeal cancer, and when combined with chemotherapy for patients with stomach and liver cancer (Macek 1984; Wang 1990).

Fu Zheng herbs, including Rx ginseng, ganoderma, Rx astragali membranaceus, Rx angelicae sinensis, Cordyceps sinensis and Fructus lycii, have been shown to enhance the body's defence mechanisms. Clinical studies, including two randomised trials, have found that the NK and OKT4

(immune-enhancing lymphocyte) cell counts were increased with the use of Fu Zheng herbs (Ning et al 1988; Ling et al 1989; Chen 1990; Yu et al 1990; Hou et al 1991; Rao et al 1991; Li 1992; Yu et al 1993; Cao et al 1994; Cheng 1994; Horie et al 1994; Lin et al 1995). These immunocytes are known to attack cancer cells. In a study of gastric cancer patients, increased survival was found in the combined treatment group receiving both Fu Zheng herbs and chemotherapy versus the group receiving chemotherapy alone. Many of these herbs are associated with an increase in cytokines, such as interferon and interleukin (Kawakita et al 1990; Jin et al 1994; Feng et al 1995). Chinese studies also suggest that healing of normal tissues may be enhanced. Anti-inflammatory constituents may diminish radiation-induced ulcers and chemotherapy-induced stomatitis (Zhu and Zhang 1993; Zhu 1994). However, these studies still need to be verified in the West, using acceptable standards and quality assurance.

Acupuncture. Multiple animal and clinical studies have also suggested that acupuncture has a positive immune-modulating effect in cancer patients (Bianchi et al 1991; Yuan and Zhou 1993; Wu et al 1994; Yang et al 1994; Liu et al 1995; Wu 1995; Sato et al 1996; Wu B et al 1996; Petti et al 1998; Zhou JQ et al 1999). In these studies, acupuncture has been shown to increase T-lymphocyte proliferation, increase NK cell activities, activate the complement system and heat-stable mitogenic humoral factor, and increase OKT4 cell counts. Inhibition of the growth of transplanted mammary cancer has also been shown in mice with the use of acupuncture. The main acupoints that were used in these studies were those that support blood formation and spleen function. These points include LI-4, LI-11, St-36, Sp-6, Sp-10, P-6, UB-20, GB-39 and GV-14. An increased level of all components (red blood cells, white blood cells and platelets) was found.

Hormonal Effects

Some Chinese herbs inhibit hormone-responsive tumour cells. PC-SPES is a combination of herbs with oestrogenic activity associated with activity against prostate cancer (DiPaola et al 1998). This study correlated laboratory activity with clinical response. On the basis of these findings, a National Cancer Institute randomised, controlled trial was initiated. Unfortunately, the clinical trial has been temporarily halted when a batch of PC-SPES was contaminated with the hormone stilboestrol and other pharmacological substances. It is not certain whether there was deliberate adulteration, accidental contamination or a biochemical cross-reaction with natural constituents.

Acupuncture may stimulate levels of steroids and other hormones, such as melatonin, somatostatin and vasoactive intestinal peptide, which could potentially have antitumour effects (Massion et al 1995; Zhang et al 1997; Zhang et al 1999). Exposure of the popliteal fossa (over the bladder meridian) to bright light modulates the circadian release of melatonin from the pineal gland (Campbell and Murphy 1998).

Cancer Prevention

TCM also emphasises appropriate nutrition according to specific constitutional and disease patterns. Green tea (Camellia sinensis) and Panax ginseng are two dietary supplements that have been extensively investigated both in the laboratory and in epidemiological studies. Both reduce the risk of cancer induction, and both may prevent cancer recurrence (Yang and Wang 1993; Kaegi 1998; Yun and Choi 1998).

Green tea contains isoflavones and a powerful antioxidant called epigallocatechin (EGC) (McKenna et al 2000). The latter may potentiate the destruction of cancer cells through the process of apoptosis (natural programmed cell death) and by inhibiting angiogenesis (new blood vessel formation that enhances tumour growth and metastasis) (Cao and Cao 1999; Fujiki et al 1999). Panax ginseng may induce the differentiation of neoplastic cells into normal tissue (Lee et al 1996). Both EGC and ginseng appear to restore normal intercellular communication through the gap junctions (Kang et al 2000), and both dietary supplements seem to work through novel mechanisms of signalling and communication through the body-mind network.

The soy bean contains genistein, which is an isoflavone with multiple anticancer effects demonstrated in the laboratory (Boik 1996). These include the induction of tumour cell death through the process of apoptosis, inhibition of cancer cell proliferation through decreasing the availability of sex hormones, inhibition of angiogenesis, inhibition of tyrosine kinase (involved in intracellular signalling from the membrane to the nucleus) and inhibition of platelet aggregation (Kim et al 1998; Li, Bhuiyan and Sarkar 1999; Li, Upadhyay et al 1999). Some epidemiological studies suggest that populations with a high soy or tofu content in their diet may have a reduced risk of breast cancer (Wu AH et al 1996; Witte et al 1997; Lu et al 2000), whereas other studies cannot confirm this link (Key et al 1999). The phytoestrogens contained within soy may reduce the symptoms of hot flushes associated with chemotherapy-induced menopause (Scambia et al 2000), although not all studies support this (Quella et al 2000). The isoflavones and phytoestrogens in soy also appear to reduce the incidence of prostate cancer, and may play a role in prevention and as an adjunctive therapy to reduce the risk of recurrence (Jacobsen et al 1998; Kamat and Lamm 1999; Moyad 1999; Stephens 1999; Adlercreutz et al 2000). Cell culture and animal xenograft studies show that treatment with soy is associated with inhibition of prostate-specific antigen, activation of NF-kappa B (a nuclear transcription factor), induction of apoptosis and inhibition of angiogenesis (Aronson et al 1999; Davis et al 1999; Zhou JR et al 1999; Davis et al 2000).

TCM herb combinations may reduce the risk of lung cancer in ex-smokers. A National Cancer Institute-sponsored study through the British Columbia Cancer Agency, led by Dr Stephen Lam, is recruiting 100 participants aged 45-74 years, who are ex-smokers, to evaluate the efficacy of a herbal combination called Anti-Cancer Preventive Health Agent (ACAPHA) (Lam S 2003, pers comm). This contains Sophora tonkinensis, Polygonum bistorta, Prunella vulgaris, Sonchus brachyotus, Dictamnus dasycarpus and Dioscorea bulbifera. In Chinese studies, ACAPHA reduced the risk of oesophageal cancer by 50% through reversing severe oesophageal dysplasia. In addition, a pilot study of 20 former heavy smokers with bronchial dysplasia treated with ACAPHA showed that after 6 months 50% had complete regression of dysplasia, compared with only 13% in the placebo group.

Psychoneuroimmunology is a scientific discipline that has produced evidence for a dynamic mutual interaction between the mind, nervous system, endocrine system and immunity. The interaction of emotions and immunocytes through molecules, such as neuropeptides, is now well recognised. In fact, the immune system can be viewed as a complex evolutionary communication system within the body-mind network (Page and Ben-Eliyahu 1997; Jessop 1998; Nutt 1998; Pert et al 1998; Rabin 1999). TCM recognises this complex interaction between personality, mood states and susceptibility to illness through malfunction of the body-mind network.

There is accumulating evidence that psychological function is linked with outcomes in cancer patients (Shekelle et al 1981; Levy and Wise 1987; Ramirez et al 1989; Orsi et al 1996; Andersen et al 1998; Watson et al 1999). There is evidence to suggest a link between mood disorders and function of the immune system. Indeed, the experience of pain and suffering is intimately connected to immunity. A mood disorder such as helplessness and hopelessness may lead to a depressed immune system. Treatment of depression and feelings of hopelessness may not only increase quality of life, but also increase survival (Spiegel et al 1989; Fawzy et al 1995; Fawzy 1999). In a cancer practice, 50% of patients suffer from clinically recognised depression. In 15% of these patients, the degree of depression is severe. Therefore treatment of depression is an important intervention in the management of the body-mind network of cancer patients.

Conventionally, clinical depression is treated with oral medication, such as amitriptyline or the newer serotonin reuptake inhibitor drugs. Studies indicate that acupuncture treatment may be an equally effective alternative treatment modality to drugs in patients with mild depression. In one study, the profile of side effects associated with acupuncture treatment was shown to be better than that with amitriptyline (Han 1986). In a single-blind, placebo-controlled study of the antidepressant mianserin, supplementary acupuncture improved the course of depression more than pharmacological treatment with the drug alone (Roschke et al 2000). Since pharmaceutical antidepressants are not usually effective until 2 weeks after starting therapy, their combination with acupuncture may enable more rapid results with fewer side effects.

Symptom Control

Cancer patients experience multiple symptoms related either to the cancer itself or to late treatment side effects. Even if a patient's cancer were clinically 'cured', the person may still be suffering from late treatment side effects. For example, radiation may cause xerostomia, trismus and skin ulceration. These side effects have an adverse effect on quality of life and are often not effectively managed by conventional Western medicine.

Chinese medicine plays a useful role in symptom supportive care for cancer patients. Symptoms that can be effectively managed include general constitutional symptoms, such as fatigue and depression, pain and specific symptoms such as gastrointestinal side effects and myelosuppression.

Cancer patients receiving chemotherapy usually develop myelosuppression (with risk of infection and bleeding) and gastrointestinal side effects (nausea, vomiting and diarrhoea). They easily become fatigued and develop a reduced appetite. In TCM terms, the chemotherapeutic agents are causing spleen and kidney deficiency, leading to a general decrease in qi and blood. Radiotherapy and chemotherapy act as 'heat toxins' that damage the yin and qi. 'Heart fire' is expressed as stomatitis; 'deficient spleen qi' is manifest as diarrhoea. Chemotherapy drugs 'disturb spleen and stomach qi', expressed physically as damage to the lining of the stomach and intestines (Rosenberg 1997). These physical expressions are only part of the disturbance in the body-mind network and will inevitably be accompanied by emotional disorders (such as depression, anxiety and insomnia) and constitutional change (such as fatigue or hyperexcitability and poor concentration). After an evaluation and diagnosis of the disturbance in the body-mind network, appropriate combinations of herbs, acupuncture, nutrition and qigong may be utilised.

Herbs. Spleen and stomach qi are supported by appropriate formulas containing Rx ginseng, poria and Rh atractylodis macrocephala (Rosenberg 1997). Depleted yin leads to dry and sore mouth, thirst, constipation and scanty dark urine. The harmonious relationship between kidney and heart is disturbed, leading to insomnia, restlessness, disorientation, palpitations and low back pain. This combination of symptoms is traditionally alleviated with combinations of Rh anemarrhenae, Cx phellodendron and Rx rhemanniae. The weakening of qi is associated with depressed immunity and susceptibility to infection and cancer progression. Medicinal mushrooms, such as ganoderma, Cordyceps sinensis and shitaki strengthen the qi, which is associated with an improved immune profile and antitumour activity. Another herb with potent immune-stimulating properties is Rx astragali membranaceus.

At least five randomised, controlled trials have shown that Chinese herbal treatment can decrease the degree of myelosuppression, reduce gastrointestinal side effects and increase the patient's appetite (Ning et al 1988; Ling et al 1989; Chen 1990; Wang 1990; Yu et al 1990; Hou et al 1991; Rao et al 1991; Li 1992; Yu et al 1993; Cao et al 1994; Cheng 1994; Horie et al 1994; Lin et al 1995). Importantly, it can also increase the probability of patients completing the scheduled chemotherapy. One randomised trial recruited 669 patients with late-stage gastric cancer (Yu et al 1993). One group of patients was treated with herbs that support the spleen and kidney function (Jian Pi Yi Shen prescription) twice daily for 4-6 weeks with concurrent chemotherapy, while another group was treated with the same type of chemotherapy alone. The combined treatment group showed significantly higher leucocyte and platelet counts with fewer general and gastrointestinal side effects. The percentage of patients completing the scheduled chemotherapy was 95% in the combined treatment group versus 74% in the group receiving chemotherapy alone (p < 0.01). Unfortunately, the quality and verification of the data from these studies, which were reported from China, are not at a high enough standard for definitive meta-analysis to be done at this stage.

In TCM, systemic Chinese herbal treatments and topical herbal applications appear to be effective in treating cancer-related pain. In one study, the effectiveness in pain control was shown to be over 90% (Yang et al 1995).

Ginger root has been shown in many clinical studies to have antiemetic activity (Mowrey and Clayson 1982; Grontved and Hentzer 1986; Grontved et al 1988; Bone et al 1990; Fischer-Rasmussen et al 1991). It appears to particularly help nausea that may be intransigent to standard antiemetics. Ginger syrup was shown to be effective in a randomised controlled trial (Keating and Chez 2002). Caution should be used with patients on anticoagulants and those with low platelet levels, since it does have anticoagulant effects at higher doses.

Vitexina (Vigna radiata) is a flavonoid herb with radio-protective effects that may be useful for reducing some side effects of radiotherapy. It treats the heat or yin-deficiency side effects of anticancer treatment, such as fatigue, restlessness, insomnia and constipation. This empty heat syndrome is characterised through tongue diagnosis, which reveals a red, denuded and cracked tongue. Since the tongue is the most densely innervated organ in the body, it may reflect the imbalance between yin and yang, via the autonomic nervous system, which in turn may influence blood flow and epithelial cell turnover through the local release of neuropeptides and cytokines. A randomised controlled trial of breast cancer patients receiving radiotherapy showed that vitexina prevented the empty heat syndrome, reduced weight loss and protected against a reduction in peripheral lymphocytes and platelets (Tran 2002).

The role of Chinese herbs, together with conventional Western pharmaceuticals, for symptom control is currently unclear. Laboratory data suggest that they can be effective modifiers of biochemical pathways, immunostimulants and signal transduction modulators. Potential detrimental interactions and idiosyncratic toxicity are possible. Future studies need to be done using more rigorous methodology and quality assurance. The use of appropriate modelling and suitable evaluative methodologies should enable the integration of Chinese herbology into an emerging model of holistic Western medicine.

Acupuncture. Acupuncture treatment at acupoint P-6 has been shown to increase the antiemetic effect of drugs for perioperative and chemotherapy-induced nausea and vomiting (Dundee et al 1986; Dundee et al 1989). Innovative randomised, single-blind, controlled trials have since confirmed these results (Al-Sadi et al 1997; Schlager et al 1998; Lee and Done 1999) and led to the National Institutes of Health (US) consensus statement that, 'acupuncture is a proven effective treatment modality for nausea and vomiting' (NIH Consensus Development Panel on Acupuncture 1998). Stimulation of P-6 may be done more conveniently with a small transcutaneous electrical nerve stimulation (TENS) device, such as the Reliefband™, which is worn like a wrist watch. A three-arm randomised, controlled trial of conventional modern antiemetics (such as the serotonin 5-HT3 antagonists), versus electro-acupuncture, versus the combination of antiemetic drugs plus acupuncture clearly demonstrated that the combination arm was the most effective for preventing nausea and vomiting (Shen et al 2000).

Pain is a common symptom of cancer. Causes of pain can be disease- or treatment-related. Acupuncture has been shown to be effective in managing pain and other symptoms in cancer patients (Thompson and Filshie 1998). In a retrospective study from the Royal Marsden Hospital (London, UK), 183 cancer patients with malignant pain, iatrogenic pain and radiation-induced chronic ulcers were treated with acupuncture (Filshie 1984; Filshie and Redman 1985). There was an improvement in 82% of the patients, but effectiveness lasted for more than 3 days in only half of the patients. Iatrogenic pain (for example, pain due to radiation fibrosis or skin ulceration) and pain due to secondary muscle spasm responded better than malignant pain. Furthermore, increased blood flow with improved healing of skin ulcers was demonstrated after treatment with acupuncture. We also have similar experience with the high but short-lasting effectiveness of acupuncture treatment in malignant pain. We suggest that acupuncture is a useful treatment modality that may best be combined with other treatments to improve pain control, resulting in reduced doses of pharmaceutical analgesics. This has the benefit of reducing the incidence and degree of drug-induced side effects.

Some patients may not be able to access an acupuncturist because of geographic restrictions or poor performance status. In addition, some patients may not tolerate needle insertions. For these patients, a TENS has the advantage of easy administration by patients or staff with minimal basic training. Recently, acupuncture-like TENS (AL-TENS) devices have been developed to mimic the treatment of acupuncture using low-frequency (eg 4 Hz), high-intensity stimulation (Pomeranz and Niznik 1987). The goal is to recruit the high threshold type III afferent nerve fibres which are potent releasers of endorphins. Recent meta-analyses (including a Cochrane Database systematic review) have shown that AL-TENS is more effective than placebo, and improves function more than standard TENS, when treating chronic pain (Patel et al 1989; Gadsby and Flowerdew 1997; Ernst and White 1998; Ghoname et al 1999). AL-TENS devices are very simple machines that patients can learn to operate in less than an hour's training. An acupoint prescription may then be given to the patient, who can administer the appropriate treatments with AL-TENS at home. The Codetron™ is a sophisticated AL-TENS device that has the advantage of reducing tolerance to its analgesic effect, by electronically rotating through a series of random electrical stimulation patterns and acupoint locations.

At the University of Texas, an electrical acupuncture-like technique called percutaneous electrical nerve stimulation has been proposed to treat pain due to bony metastasis (Ahmed et al 1998). In this technique, an acupuncture needle is inserted down to the periosteum of the affected bone and another needle is inserted into the nearby soft tissue. These are then electrically stimulated. This has demonstrated promising results for pain relief due to bony metastasis that is not responding to other treatment modalities.

Other symptoms that may be helped by acupuncture include constipation, trismus (post-radiotherapy contracture of the masseter muscle) (Ernst and White 1999), breathlessness (Filshie et al 1996), radiotherapy-associated proctitis (Zhang 1987), hiccups (Yan 1988), persistent yawning (Wong and Sagar 2000) and dysphagia secondary to an oesophageal neoplasm (Feng 1984). Suppression of anxiety by acupuncture may be associated with an increase in the pain threshold (Widerstrom-Noga et al 1998). Acupuncture may also play a role in the treatment of fatigue and malignant cachexia through the modulation of cytokines and hormones (Lissoni et al 1996; Campbell and Murphy 1998; Glaus 1998; Stone et al 1998).

Patients who are in remission from their cancer may still continue to experience late treatment side effects with reduced quality of life. Radiation-induced xerostomia (dry mouth) is one of the distressing late side effects seen in patients who received radiation treatment that involved the parotid glands. The presence of this condition renders patients with loss of taste and difficulty in speaking and swallowing. Recently, acupuncture treatment has been found to increase blood flow to the parotid glands and may stimulate tissue regeneration in parotid glands damaged by radiotherapy (Blom et al 1992; Talal et al 1992; Blom et al 1993). A randomised controlled trial of 38 patients with radiation xerostomia was reported from the Karolinska Institute in Sweden (Blom et al 1996). Subjects were randomised to either deep acupuncture treatment or superficial acupuncture treatment. The latter group was used as the control, despite previous evidence that superficial acupuncture treatment can have a certain degree of effectiveness and should not be used as a control in acupuncture treatment trials. In this study it was found that in both groups there was more than a 20% increase in saliva flow rate in more than 50% of patients. In the deep acupuncture group, 68% of patients demonstrated an increase in salivary flow rate. Changes in the control group were smaller and appeared after a longer latency phase. Moreover, patients in the treatment group reported less dryness, less hoarseness and improved taste. In another study, 70 patients with xerostomia due to either Sjögren's syndrome or irradiation were treated with acupuncture (Blom and Lundeberg 2000). A statistically significant increase in unstimulated and stimulated salivary flow rates was found in all patients immediately after acupuncture treatment and at up to 6 months follow-up. After a review at 3 years, patients who chose to be treated with additional acupuncture demonstrated a consistently higher median salivary flow rate than those not having additional acupuncture. Despite some limitations in the study design, both studies provide evidence suggesting acupuncture can be effective in treating radiation-induced xerostomia, with minimal side effects. In a prospective, single-cohort, visual analogue-assessed study of acupuncture in palliative care patients with xerostomia, there was a highly significant alleviation of subjective xerostomia (Rydholm and Strang 1999). Other studies are confirming the clinical use of acupuncture for relief of radiation-induced xerostomia (Johnstone et al 2001).

At the Hamilton Regional Cancer Centre (Canada), a phase I and II study of AL-TENS in the treatment of radiation-induced xerostomia has been completed (Wong et al 2003). Forty-five patients were randomised into three treatment groups with AL-TENS stimulation using the Codetron™ to three different sets of acupuncture points: group A CV-24, St-36, Sp-6, LI-4; group B CV-24, St-36, Sp-6, P-6; and group C CV-24, St-5, St-6, Sp-6, P-6. The goal of this study was to determine the optimum pattern of stimulation (based on TCM theory) prior to designing a placebo-controlled study. AL-TENS treatment was administered twice a week for a total of 12 weeks. Unstimulated and stimulated salivary flow rates before, during and after treatment were measured, and a survey of the patients' quality of life was assessed during a follow-up of 1 year. There was an improvement in xerostomia symptoms with a mean increase in the visual analogue score at 3 and 6 months after treatment completion. All patients demonstrated a significant increase in the mean basal and citric acid-primed saliva production. The results suggest that Codetron™ treatment improves saliva production and related symptoms in patients with radiation-induced xerostomia. Treatment effects are sustained at least 6 months after completion of treatment.

Acupuncture can reduce the hot flushes associated with anticancer hormone therapy. Three prospective, uncontrolled cohort studies have been done, one in men castrated for prostate cancer, and two others in women taking tamoxifen for breast cancer. They all demonstrated a reduction in vasomotor symptoms (Hammar et al 1999; Tukmachi 2000; Cumins and Brunt 2001).

Conclusions

There is emerging scientific evidence that Chinese medicine can play an important role in the supportive care of cancer patients. There is enough preliminary evidence to encourage good quality clinical trials to evaluate the efficacy of integrating Chinese medicine into Western cancer care (Fontanarosa and Lundberg 1998; Sagar 1998; Sagar 1999; Tagliaferri et al 2001). Currently, the evidence for the utility of TCM in cancer care is promising, but prospective randomised clinical trials for specific clinical scenarios are necessary to obtain reliable and generalisable data. Appropriate stratification and individualisation according to TCM diagnostic criteria is possible within the context of a randomised, controlled trial (Bensoussan et al 1998). We believe that an evidence-based approach can be integrated into an individualised therapeutic plan and that there is still a major role for individual belief systems and psychospiritual experience. Assessment and measurement of coping strategies, maintenance of function, quality of life and patient satisfaction is important. We are hopeful that future integration of different models of health, such as TCM, may lead to further improvement of cancer patients' survival and quality of life (Sagar 2001).

Acknowledgements

Christina M Garchinski for organising references.